Dr. Edler received his bachelor's degree in Biochemistry and Molecular Biology from Marquette University in 1997. He completed his doctoral degree in Pharmacology and Toxicology from the University of Utah in 2003. He then continued his training at the National Cancer Institute as a Postdoctoral Fellow in the laboratory of Dr. Ernest Hamel where he developed several screens to study the structure-activity relationship for several libraries of experimental anti-cancers compounds. This work lead to a Principal Investigator position at the small biotech company, Taxolog, where he was the head of the screening technologies laboratory. His team developed several new screens to assess the company's proprietary compound library in the areas of inflammation, wound healing and oncology.
In 2013, Dr. Edler joined the lab of Dr. A.J. Baucum in the Department of Biology at Indiana University Purdue University Indianapolis (IUPUI) as a Scholar Scientist. His research focused on the underlying molecular changes that occur after the development of Parkinson's disease (PD) utilizing a chemically induced murine model of PD. Additionally, Dr. Edler helped to develop genetically modified human stem cells using CRISPR/Cas9 in the lab of Dr. Jason Meyer.
In 2018, Dr. Edler joined Indiana University School of Medicine in the Department of Medical and Molecular Genetics as an Assistant Scientist. He has been the Laboratory Director for the Indiana University Genetics Biobank (IUGB) led by Dr. Tatiana Foroud. The IUGB is a state of the art biospecimen repository housing thousands of samples from multiple NIH and non-profit organizations such as the Michael J. Fox Foundation. Dr. Edler is responsible for ensuring university, state and federal regulations are in compliance. He is also responsible for ensuring the highest level of quality control and sample quality by ensuring that standard operating procedures (SOPs) guide all biorepository functions.